Search by Drug Name or NDC

    NDC 00004-1100-20 Xeloda 150 mg/1 Details

    Xeloda 150 mg/1

    Xeloda is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Genentech, Inc.. The primary component is CAPECITABINE.

    Product Information

    NDC 00004-1100
    Product ID 0004-1100_1187214d-f028-4db4-a59c-ab3bb029c46f
    Associated GPIs 21300005000320
    GCN Sequence Number 039780
    GCN Sequence Number Description capecitabine TABLET 150 MG ORAL
    HIC3 V1B
    HIC3 Description ANTINEOPLASTIC - ANTIMETABOLITES
    GCN 31611
    HICL Sequence Number 018385
    HICL Sequence Number Description CAPECITABINE
    Brand/Generic Brand
    Proprietary Name Xeloda
    Proprietary Name Suffix n/a
    Non-Proprietary Name capecitabine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name CAPECITABINE
    Labeler Name Genentech, Inc.
    Pharmaceutical Class Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA020896
    Listing Certified Through 2024-12-31

    Package

    NDC 00004-1100-20 (00004110020)

    NDC Package Code 0004-1100-20
    Billing NDC 00004110020
    Package 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0004-1100-20)
    Marketing Start Date 1998-04-30
    NDC Exclude Flag N
    Pricing Information N/A